Accuray Tops Q3 EPS by 3c
- ByInvesting.com-
Accuray (NASDAQ:ARAY) reported Q3 EPS of ($0.01), $0.03 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $96.2 million versus the consensus estimate...
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Accuray Incorporated (ARAY)
NASDAQ
Symbol | Exchange | Currency |
|---|
2.060
-0.010(-0.48%)
- Volume:139,297
- Day's Range:2.050 - 2.135
- 52 wk Range:1.700 - 5.930
Earnings results expected today
ARAY Overview
- Prev. Close
- 2.07
- Day's Range
- 2.05-2.135
- Revenue
- 430.83M
- Open
- 2.11
- 52 wk Range
- 1.7-5.93
- EPS
- -0.14
- Volume
- 139,297
- Market Cap
- 193.96M
- Dividend (Yield)
- N/A(N/A)
- Average Vol. (3m)
- 1,162,243
- P/E Ratio
- -
- Beta
- 1.88
- 1-Year Change
- -47.99%
- Shares Outstanding
- 92,802,213
- Next Earnings Date
- Aug 10, 2022
What is your sentiment on Accuray?
or
Vote to see community's results!
Accuray Incorporated News
- 3 Medical Equipment Stocks Under $10 to Buy Now
- ByStockNews-
The medical equipment industry was hit hard when the treatment of COVID-19 cases became a priority for hospitals last year. However, the industry is mounting a solid recovery this...
- Ex-Deerfield partners get prison in case over U.S. agency leaks
- ByReuters-
By Brendan Pierson NEW YORK (Reuters) - Two former partners of the hedge fund Deerfield Management were sentenced to three years in prison on Thursday after being convicted of...
Accuray Incorporated Analysis
- Biotech Shares Too Risky? Here's An ETF For Safely Avoiding The Volatility
Biotechnology stocks represent companies that research, develop or market healthcare-related therapies or products. They typically use living organisms, biological systems, or...
- Stocks Finally Take a Break After Eight Days of Record Highs
SPECIAL ALERT: The November episode of the Zacks Ultimate Strategy Session is now available for viewing! Tune in to this “must-see” event when Kevin Matras, Tracey...
- Here's Why You Should Invest In DaVita (DVA) Stock Right Now
DaVita Inc. (NYSE:DVA) continues to benefit from solid and steadily expanding international presence, DaVita Kidney Care and prudent acquisition of dialysis centers.In a...
Accuray Incorporated Company Profile
Accuray Incorporated Company Profile
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The Company's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.
Read More
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Buy | Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Buy | Strong Buy | Sell | Strong Sell | Strong Sell |
| Summary | Strong Buy | Strong Buy | Sell | Strong Sell | Strong Sell |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 175.47 | 176.42 | 175.32 | +0.96 | +0.55% | 887.75K | NASDAQ | |||
| 261.60 | 263.68 | 261.37 | +1.54 | +0.59% | 1.15M | NYSE | |||
| 8.51 | 8.61 | 8.28 | +0.22 | +2.65% | 1.76M | NYSE | |||
| 3.555 | 3.59 | 3.469 | +0.105 | +3.04% | 5.34M | NYSE | |||
| 30.73 | 30.87 | 30.04 | +0.31 | +1.00% | 1.81M | NYSE | |||
| 190.14 | 191.25 | 187.49 | +4.11 | +2.21% | 760.95K | NYSE | |||
| 2.20 | 2.65 | 2.03 | +0.740 | +50.69% | 33.27M | NASDAQ | |||
| 39.48 | 41.98 | 38.64 | -0.89 | -2.21% | 2.52M | NYSE | |||
| 1.185 | 1.22 | 1.17 | +0.0050 | +0.42% | 1.45M | NYSE | |||
| 54.33 | 54.53 | 53.81 | +1.61 | +3.05% | 1.49M | NYSE | |||
| 1.13 | 1.13 | 1.10 | -0.0100 | -0.88% | 53.74K | NYSE | |||
| 46.46 | 46.98 | 44.85 | +1.53 | +3.41% | 1.52M | NYSE | |||
| 49.56 | 50.04 | 49.51 | -0.22 | -0.44% | 5.28M | NYSE | |||
| 97.80 | 98.76 | 95.61 | +2.26 | +2.37% | 38.86M | NASDAQ | |||
| 43.94 | 43.96 | 43.56 | +0.52 | +1.20% | 855.09K | NYSE |
- Jan 24, 2019, 21:29this stock has potential to finally increase especially due to sales in China now.
- Jan 24, 2020, 18:52In in Andy. Got me 3 shares I'm holding on to for a while!